What is the official website of Sandoz Iberia ?

The official website of Sandoz Iberia is https://sandozfarma.es/.

What is Sandoz Iberia's cybersecurity risk score?

Sandoz Iberia has an AI-generated cybersecurity risk score of 753 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Sandoz Iberia experienced?

According to Rankiteo, Sandoz Iberia currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Sandoz Iberia been affected by any supply chain cyber incidents ?

According to Rankiteo, Sandoz Iberia has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Sandoz Iberia have SOC 2 Type 1 certification ?

According to Rankiteo, Sandoz Iberia is not certified under SOC 2 Type 1.

Does Sandoz Iberia have SOC 2 Type 2 certification ?

According to Rankiteo, Sandoz Iberia does not hold a SOC 2 Type 2 certification.

Does Sandoz Iberia comply with GDPR ?

According to Rankiteo, Sandoz Iberia is not listed as GDPR compliant.

Does Sandoz Iberia have PCI DSS certification ?

According to Rankiteo, Sandoz Iberia does not currently maintain PCI DSS compliance.

Does Sandoz Iberia comply with HIPAA ?

According to Rankiteo, Sandoz Iberia is not compliant with HIPAA regulations.

Does Sandoz Iberia have ISO 27001 certification ?

According to Rankiteo,Sandoz Iberia is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Sandoz Iberia operate in ?

Sandoz Iberia operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Sandoz Iberia have ?

Sandoz Iberia employs approximately 122 people worldwide.

Does Sandoz Iberia own any subsidiaries ?

Sandoz Iberia presently has no subsidiaries across any sectors.

How many LinkedIn followers does Sandoz Iberia have ?

Sandoz Iberia's official LinkedIn profile has approximately 19,172 followers.

What is the NAICS classification code for Sandoz Iberia ?

Sandoz Iberia is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Sandoz Iberia have a Crunchbase profile ?

No, Sandoz Iberia does not have a profile on Crunchbase.

Does Sandoz Iberia have a LinkedIn profile ?

Yes, Sandoz Iberia maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/sandoziberia.

How many cybersecurity incidents has Sandoz Iberia experienced ?

As of June 9, 2026, Rankiteo reports that Sandoz Iberia has not experienced any cybersecurity incidents.

How many peer or competitor companies does Sandoz Iberia have ?

Sandoz Iberia has an estimated 5,682 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Sandoz Iberia

Boost Score +25 with badge (5 left)

753

/1000

Fair

778

/1000

Fair

Sandoz Iberia Vendor Cyber Rating & Cyber Score

sandozfarma.es

Add Your Compliance Badge

En Sandoz, nuestro propósito es ser pioneros en facilitar el acceso a la salud de los pacientes y aspiramos a ser la empresa de genéricos y biosimilares líder y más valorada del mundo. El origen de la compañía se remonta a Basilea, Suiza, en 1886. Nos enorgullecemos de nuestra larga trayectoria, que hoy es sinónimo de calidad, fiabilidad e innovación. Más de 20.000 personas de 100 nacionalidades trabajamos juntas para garantizar que Sandoz proporcione 900 millones de tratamientos a pacientes anuales, lo que genera un ahorro sanitario y un impacto social aún mayor. Somos el número 1 en el mercado mundial de genéricos si se comparan las ventas netas, el segundo en biosimilares y la empresa de genéricos líder en Europa. Estamos trabajando

Sandoz Iberia A.I CyberSecurity Scoring

Scoring History

Sandoz Iberia

Sandoz Iberia CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

Sandoz Iberia Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Sandoz Iberia

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Iberia in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Sandoz Iberia in 2026.

Incident Types Sandoz Iberia vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Sandoz Iberia in 2026.

Incident History - Sandoz Iberia (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Sandoz Iberia Subsidiaries

Sandoz Iberia

Pharmaceutical Manufacturing

Website: https://sandozfarma.es/

Company Size: 501-1,000 employees

SandozPharmaceutical Manufacturing

Sandoz ItaliaPharmaceutical Manufacturing

Sandoz RomaniaPharmaceutical Manufacturing

Sandoz BelgiumPharmaceutical Manufacturing

Sandoz CanadaPharmaceutical Manufacturing

Sandoz do BrasilFabricação de produtos farmoquímicos e farmacêuticos

Lek PharmaceuticalsPharmaceutical Manufacturing

Sandoz FrancePharmaceutical Manufacturing

Sandoz PolskaPharmaceutical Manufacturing

Sandoz EgyptPharmaceutical Manufacturing

Sandoz in DeutschlandPharmaceutical Manufacturing

Sandoz Czech RepublicPharmaceutical Manufacturing

Sandoz India Pvt LtdPharmaceutical Manufacturing

Sandoz HrvatskaPharmaceutical Manufacturing

Life at SandozArzneimittelherstellung

Sandoz UK & IrelandPharmaceutical Manufacturing

Sandoz SrbijaPharmaceutical Manufacturing

Sandoz HungáriaPharmaceutical Manufacturing

Sandoz ÖsterreichPharmaceutical Manufacturing

Sandoz SverigePharmaceutical Manufacturing

Sandoz MéxicoPharmaceutical Manufacturing

Sandoz Australia & New ZealandPharmaceutical Manufacturing

Sandoz DanmarkPharmaceutical Manufacturing

Sandoz NederlandPharmaceutical Manufacturing

Loading…

Sandoz Iberia Similar Companies

Grifols

cb linktr.ee

Grifols is a global healthcare company founded in Barcelona in 1909 committed to improving the health and well-being of people all over the world. A leader in essential plasma-derived medicines and transfusion medicine, we develop, produce and provide innovative healthcare services and solutions in more than 110 countries. Patient needs and our ever-growing knowledge of many chronic, rare and prevalent diseases, sometimes life-threatening, drive our innovation in plasma-based therapies and other biopharmaceuticals to enhance quality of life. Grifols is focused on treating conditions across a broad range of therapeutic areas: immunology, hepatology and intensive care, pulmonology, hematology, neurology and infectious diseases. With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. People are at the heart of what we do, and we strive to create an inclusive, diverse, fair and equal society. Maintaining and promoting a workforce that reflects this reality leads to enhanced professional relationships and helps us to give our best to patients, donors and customers. In 2024, Grifols was named one of TIME’s ‘World’s Best Companies’ for the second year in a row, reaffirming our commitment to excellence. We were also recognized by Forbes as one of the "Best Employers for Women 2023," reflecting our dedication to fostering an inclusive and supportive workplace for all. To maintain a positive community and overall respectful communication, please keep our community guidelines in mind.

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Novo Nordisk

novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 77,000 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Merck Group

merckgroup.com

This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, and Electronics. Together, we dream big and are passionate about caring for our rich mix of people, customers, patients, and the planet. We believe in the positive power of science and technology. It has determined our actions since 1668 and inspires us to continue researching for a future worth living. As a family-owned company with over 350 years of experience, we stand for sustainability, responsibility, and innovative strength. We take pride in being a diverse and inclusive company that values and fosters the talents and abilities of our employees. That's why we are always looking for curious minds that see themselves imagining the unimaginable with us. Work your Magic and join Merck. Legal Disclaimer: www.merckgroup.com/en/legal-disclaimer.html Data Privacy Declaration: www.merckgroup.com/en/privacy-statement

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

Teva Pharmaceuticals

tevapharm.com

Teva Pharmaceuticals is a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva’s commitment has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients’ needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how we make it happen, visit www.tevapharm.com. Our community guidelines may be found here: https://www.tevapharm.com/news-and-media/teva-social-media-guidelines/ Please note that adverse effects for any of our products should be reported at: https://www.tevapharm.com/teva-medical-information/report-a-side-effect-form/ Product-specific questions should be directed to Teva or Teva Group subsidiaries in your country. Contact details and Teva's Pharmacovigilance Privacy Policy may be found here: http://www.tevapharm.com/contact_us/

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

AUROBINDO PHARMA LTD

aurobindo.com

Aurobindo Pharma Limited (NSE: AUROPHARMA, BSE: 524804, Reuters: ARBN.NS, Bloomberg: ARBP IN) is an integrated global pharmaceutical company headquartered in Hyderabad, India. The Company develops, manufactures, and markets a wide range of generic pharmaceuticals, branded specialty drugs, and active pharmaceutical ingredients (APIs) across more than 150 countries. It is ranked among the top 10 generic companies in eight European nations and holds the distinction of being the largest generic pharmaceutical company in the United States. With over 30 state-of-the-art manufacturing and packaging facilities approved by leading global regulatory authorities including USFDA, UK MHRA, EDQM, Japan PMDA, WHO, Health Canada, South Africa MCC, and Brazil ANVISA, Aurobindo Pharma ensures the highest standards of quality. Its robust portfolio spans eight major therapeutic areas: Central Nervous System (CNS), Antiretroviral (ARV), Cardiovascular (CVS), Antibiotics, Gastroenterology, Anti-diabetics, Oncology, and Dermatology, supported by a strong R&D infrastructure that drives innovation, affordability, and accessibility.

Novartis

cb novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

Loading…

NEWS

Sandoz Iberia CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-44541

SUMMARY

Fides is an open-source privacy engineering platform. From version 2.33.0 to before version 2.84.5, there is a DOM-based XSS vulnerability in fides.js via the fides_description override. This issue has been patched in version 2.84.5.

Published

Date2026-06-08

Updated

Date2026-06-08

RISK INFORMATION (Score: )

cvss4

Base Score: 7.0

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:N/VI:N/VA:N/SC:H/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-49141

SUMMARY

WACRM prior to commit 73041bf contain an authorization bypass vulnerability in the automation engine that allows authenticated attackers to access and modify contacts belonging to other tenants by supplying an arbitrary caller-controlled contact_id in the POST request body without tenant ownership verification. Attackers can exploit the service-role client that bypasses row-level security to modify victim contact fields including name, email, and company across tenant boundaries using only a known contact UUID.

Published

Date2026-06-08

Updated

Date2026-06-08

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: HIGH

CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:C/C:L/I:H/A:N

cvss4

Base Score: 5.1

Complexity: HIGH

CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:N/VI:N/VA:N/SC:L/SI:H/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

4.7

Exploitability

1.8

REFERENCES

CVE-2026-47345

SUMMARY

Namespace attributes are not encoded correctly during HTML serialization. This allows bypassing the cross-site scripting prevention mechanism of typo3/html-sanitizer before version 2.3.2.

Published

Date2026-06-08

Updated

Date2026-06-08

RISK INFORMATION (Score: )

cvss4

Base Score: 5.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-47344

SUMMARY

When ALLOW_INSECURE_RAW_TEXT is enabled, whitespace-variant closing tags (e.g., </style\t>) are not recognized by the sanitizer but accepted by browsers as valid end tags, allowing subsequent content to escape sanitization. This allows bypassing the cross-site scripting prevention mechanism of typo3/html-sanitizer before version 2.3.2.

Published

Date2026-06-08

Updated

Date2026-06-08

RISK INFORMATION (Score: )

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:P/PR:L/UI:P/VC:N/VI:N/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-46484

SUMMARY

Headplane is a feature-complete Web UI for Headscale. Prior to versions 0.6.3 and 0.7.0-beta.3, Headplane was vulnerable to a path traversal / authorization bypass in the Headscale API client used by node and user rename operations. This issue has been patched in versions 0.6.3 and 0.7.0-beta.3.

Published

Date2026-06-08

Updated

Date2026-06-08

RISK INFORMATION (Score: 8.1)

cvss3

Base Score: 8.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:H

Impact Score

5.2

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…